🇺🇸 FDA
Patent

US 11096965

Compositions and methods related to polycytotoxic T cells

granted A61KA61K38/20A61K38/2013

Quick answer

US patent 11096965 (Compositions and methods related to polycytotoxic T cells) held by The Regents of the University of California expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/20, A61K38/2013, A61K38/2046, A61K38/2086